Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 2098713Generated: October 29, 2026

4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole → 2-(1H-Indazol-4-yl)-4-morpholinothieno[3,2-d]pyrimidin-6-amine

https://huagongshe.com/reaction/2098713

Reaction equation

Participants

RoleNameHCIDCharge
Reactant4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazoleHCID 45480186—
ReactantTert-butyl 2-chloro-4-morpholinothieno[3,2-d]pyrimidin-6-ylcarbamateHCID 59592872—
Product2-(1H-Indazol-4-yl)-4-morpholinothieno[3,2-d]pyrimidin-6-amineHCID 59592924—

Reaction Steps

Tert-butyl 2-chloro-4-morpholinothieno[3,2-d]pyrimidin-6-ylcarbamate (50 mg) was coupled to 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole 7 via General Procedure A. The product was purified by reverse phase HPLC to yield 8.8 mg of 225. MS (Q1) 353 (M)+

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS08450315B2
Source datasetuspto-grants-2013_05
ORD IDord-9c5db45bd3194415b4defe3591ea0d01
Source noteuspto-grants-2013_05